We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App

Non-Invasive Sensor Monitors Changes in Saliva Compositions to Rapidly Diagnose Diabetes

By LabMedica International staff writers
Posted on 06 Oct 2023
Print article
Image: The colorimetric-based multiple sensor monitors saliva compositions for detecting diabetes (Photo courtesy of 123RF)
Image: The colorimetric-based multiple sensor monitors saliva compositions for detecting diabetes (Photo courtesy of 123RF)

Diabetes is a metabolic disorder that commonly affects people who are over 45, have a family history of the disease, poor diet, or high BMI. Poor management of diabetes can lead to severe complications like heart disease, kidney problems, and amputations. To keep the condition in check, it's crucial for patients to regularly test their glucose levels using methods like fasting blood glucose (FBG), oral glucose tolerance test (OGTT), and glycated hemoglobin (HbA1c) tests. Now, researchers have introduced a new way to monitor glucose levels through a non-invasive sensor that analyzes body fluids like saliva.

Scientists at the Baqiyatallah University of Medical Sciences (Tehran, Iran) have created a unique sensor that can identify diabetic patients by analyzing the metabolic changes in their saliva. This sensor uses an origami-like paper substrate made of two layers folded together. A saliva sample is placed on one layer and soaks through to the second layer where it interacts with sensor elements. Organic dyes serve as the sensor's receptors. Depending on their molecular structure, these dyes capture compounds in the saliva, resulting in visible color changes, according to the study published in Scientific Reports.

During clinical trials, this sensor demonstrated that it was capable of distinguishing between the chemical compositions of saliva from diabetic and non-diabetic individuals. It could also estimate the blood glucose levels or ranges and provide consistent results when analyzing specific samples. The color changes in the receptors were solely due to alterations in the saliva's metabolic profile. The sensor offers several benefits such as simplicity, portability, and reliable readings, making it a strong candidate to replace existing glucose monitoring methods. However, one current limitation is that the saliva samples need to be centrifuged, so the sensor is only suitable for use in clinical labs at this point.

Related Links:
Baqiyatallah University of Medical Sciences 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
POCT Fluorescent Immunoassay Analyzer
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article



view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more


view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more


view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.